BiVACOR, the US-based company behind the world’s first rotary artificial heart has located its international office into the Gold Coast Health and Knowledge Precinct where it will conduct final blood compatibility R&D with the world-class Griffith University Mechanobiology Research lab. The company hopes to implant its revolutionary total artificial heart device into the first patients within 2-5 years.
CEO Daniel Timms talks about the technology and the Gold Coast advantage.